The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma

被引:58
作者
Wang, Wentao [1 ,2 ]
Guo, Yaxun [1 ,2 ]
Zhong, Jingtao [3 ]
Wang, Qi [1 ]
Wang, Xin [1 ,2 ]
Wei, Honglong [1 ,2 ]
Li, Jie [1 ,2 ]
Xiu, Peng [1 ,2 ]
机构
[1] Shandong Univ, Shandong Qianfoshan Hosp, Cheeloo Coll Med, Dept Gen Surg, Jinan 250014, Shandong, Peoples R China
[2] Shandong First Med Univ, Hosp 1, Shandong Prov Qianfoshan Hosp, Dept Gen Surg, Jinan, Peoples R China
[3] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Hepatobiliary Surg, Jinan, Peoples R China
关键词
ADJUVANT TRANSARTERIAL CHEMOEMBOLIZATION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CURATIVE RESECTION; GROSS CLASSIFICATION; LIVER RESECTION; RECURRENCE; SORAFENIB; RISK; SURVIVAL; PREDICT;
D O I
10.1038/s41598-021-82058-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most common and most lethal malignant tumors in the world. Microvascular invasion (MVI) is a major risk factor for survival outcomes and intrahepatic metastasis after resection in patients with HCC. Relevant English literatures retrieved using PubMed on the research progress of MVI in patients with HCC were reviewed. For HCC patients, especially those with MVI, it is very important to develop a comprehensive and sequential treatment plan to support the long-term survival of patients. This manuscript reviewed and analyzed the risk factors for MVI; the preoperative prediction of MVI, which informs the selection of surgical strategies; and the current situation and future direction of comprehensive postoperative treatment strategies; to provide a basis for the comprehensive treatment of HCC patients with MVI. For HCC patients with MVI, the preoperative prediction of MVI may play a certain guiding role in planning procedures, and the comprehensive sequential postoperative pathological detection of HCC MVI may provide a basis for treatment decisions.
引用
收藏
页数:10
相关论文
共 83 条
  • [1] [Anonymous], 2015, Zhonghua Gan Zang Bing Za Zhi, V23, P321
  • [2] A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma
    Ariizumi, Shun-ichi
    Kitagawa, Koichi
    Kotera, Yoshihito
    Takahashi, Yutaka
    Katagiri, Satoshi
    Kuwatsuru, Ryohei
    Yamamoto, Masakazu
    [J]. JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (04) : 575 - 585
  • [3] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
    Bruix, Jordi
    Qin, Shukui
    Merle, Philippe
    Granito, Alessandro
    Huang, Yi-Hsiang
    Bodoky, Gyrogy
    Pracht, Marc
    Yokosuka, Osamu
    Rosmorduc, Olivier
    Breder, Valeriy
    Gerolami, Rene
    Masi, Gianluca
    Ross, Paul J.
    Song, Tianqiang
    Bronowicki, Jean-Pierre
    Ollivier-Hourmand, Isabelle
    Kudo, Masatoshi
    Cheng, Ann-Lii
    Llovet, Josep M.
    Finn, Richard S.
    LeBerre, Marie-Aude
    Baumhauer, Annette
    Meinhardt, Gerold
    Han, Guohong
    [J]. LANCET, 2017, 389 (10064) : 56 - 66
  • [4] Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
    Chen, Liping
    Zhang, Qi
    Chang, Wenjun
    Du, Yan
    Zhang, Hongwei
    Cao, Guangwen
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) : 1977 - 1987
  • [5] Cancer incidence and mortality in China, 2014
    Chen, Wanqing
    Sun, Kexin
    Zheng, Rongshou
    Zeng, Hongmei
    Zhang, Siwei
    Xia, Changfa
    Yang, Zhixun
    Li, He
    Zou, Xiaonong
    He, Jie
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (01) : 1 - 12
  • [6] Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis
    Chen, Zhen-Hua
    Zhang, Xiu-Ping
    Zhou, Teng-Fei
    Wang, Kang
    Wang, Hang
    Chai, Zong-Tao
    Shi, Jie
    Guo, Wei-Xing
    Cheng, Shu-Qun
    [J]. EJSO, 2019, 45 (11): : 2188 - 2196
  • [7] Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    Cheng, Ann-Lii
    Kang, Yoon-Koo
    Chen, Zhendong
    Tsao, Chao-Jung
    Qin, Shukui
    Kim, Jun Suk
    Luo, Rongcheng
    Feng, Jifeng
    Ye, Shenglong
    Yang, Tsai-Sheng
    Xu, Jianming
    Sun, Yan
    Liang, Houjie
    Liu, Jiwei
    Wang, Jiejun
    Tak, Won Young
    Pan, Hongming
    Burock, Karin
    Zou, Jessie
    Voliotis, Dimitris
    Guan, Zhongzhen
    [J]. LANCET ONCOLOGY, 2009, 10 (01) : 25 - 34
  • [8] MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior
    Cho, Eun-Suk
    Choi, Jin-Young
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2015, 16 (03) : 449 - 464
  • [9] Prediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation
    Chou, Chen-Te
    Chen, Ran-Chou
    Lin, Wei-Chan
    Ko, Chih-Jan
    Chen, Chia-Bang
    Chen, Yao-Li
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (03) : W253 - W259
  • [10] Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: A Lesson from 229 Consecutive Cases of Curative Liver Resection
    Eguchi, Susumu
    Takatsuki, Mitsuhisa
    Hidaka, Masaaki
    Soyama, Akihiko
    Tomonaga, Tetsuo
    Muraoka, Izumi
    Kanematsu, Takashi
    [J]. WORLD JOURNAL OF SURGERY, 2010, 34 (05) : 1034 - 1038